ALTH |

Mike Havrilla

Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities
on Sep 30, 2009 • ACCP.OB, ALTH, BIIB
BioMed News Bytes: NicOx, Allos, Pressure BioSciences, YM BioSciences
on Sep 25, 2009 • ALTH, IGK, NICXF.PK
FDA Calendar: 2H09 Binary Event Trades
on Jul 27, 2009 • ACAD, AEZS, ALKS
Access Pharma: Deep Pipeline, Shallow Valuation
on Jul 15, 2009 • ACCP.OB, AEZS, ALTH
FDA Calendar Updates: King Pharma, Pain Therapeutics
on Jul 08, 2009 • ALTH, CBST, DRRX
FDA Calendar: 18 Hot Summer Trades
on Jun 16, 2009 • ACUR, AEZS, ALTH
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
on Jun 01, 2009 • ALTH, AZN, BVTI.PK
FDA, Clinical Trial Updates: MAP Pharma, Cytokinetics, Hemispherx Post Big Gains
on May 27, 2009 • ALTH, AMGN, BMY
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
on May 18, 2009 • ALTH, AMGN, CRGN
Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
on May 15, 2009 • ALTH, CADX, NVS
Allos Therapeutics: Smallcap Biotech with FDA Catalyst
on Apr 27, 2009 • ALTH
FDA, Clinical Trial Calendar Updates: Thoratec, Allos Therapeutics
on Apr 21, 2009 • ALTH, THOR
FDA and Clinical Trial Updates: Dyax Secures Narrow Approval for Kalbitor
on Mar 26, 2009 • ALTH, BIOD, CLSN

Articles by Ticker

AA, AAI, AAPL, AAWW, ABBC, ABFS, ABII, ABIO, ABMD, ABT, ABTL, ABV, ABX, ACAD, ACCP.OB, ACEL, ACHN, ACL, ACLI, ACOR, ACTC, ACTC.PK, ACUR, ACUS, ADAM, ADLR, ADLS, ADLS.OB, AET, AEZS, AFFX, AFFY, AFL, AGEN, AGN, AHBIF.PK, AIQ, AIRM, AIS, AKRX, ALEX, ALGT, ALK, ALKS, ALNPY.PK, ALNY, ALO, ALPMF.PK, ALTH, ALV,

Latest Comments on Mike Havrilla's Articles

unblock school on Novartis: An Ex-U.S. Proxy for Global Healthcare: Thanks for great post Mike, Delta more »
drgmoney on Access Pharma Looking for Smooth U.S. MuGard Launch in 2010: Do you know if the post marketing Data on Mugard in Europe will be... more »
jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: Thanks Charlie - I didn't know the stats off the top of my head... more »
Super Stock Timer on BioMed News Bytes: Cytori, Questcor: 11-7-09 - BUY DNDN ON THE FIRST CLOSE ABOVE 29.00 - WALTER - SUPER... more »
Charlie L on EXACT Sciences: Buy and Hold for Long-Term Upside: Agree that $300 every 3 years is a bargain compared to a $2,000... more »
jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: $300 per test is an absolute bargain to detect CRC early. the... more »
BioGuy on A 130 / 30 Global Pharma Strategy : Good ideas, the generic pharmaceutical market will do well. My... more »
Dr. Bone on A 130 / 30 Global Pharma Strategy : This index sounds very interesting. Is there a way you can... more »
TX Gal 4Evr on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Have you not heard of 'change' or 'growth' or 'variety'?? It's... more »
dual cit on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Not what I want to hear from you. I have grown accustomed to you... more »
hoopdreamerz@yahoo.com on EXACT Sciences: Patience Required for Long-Term Upside: That's funny they compared their data with OncoMethylone (i had... more »
researchbio48 on Bio-Pharma, Diagnostics Buyout Binge Begins: Hi Mike - not sure how often you upday this link but I was hoping... more »
Mike Havrilla on Unilife: Medical Device Innovator Creating Jobs in Pennsylvania: NEH, The major investment and agreement with Sanofi (SNY) may give... more »
NEH on Unilife: Medical Device Innovator Creating Jobs in Pennsylvania: I love it Mike - it's exactly the kind of under-the-radar... more »
tappy on BioSante Pharma's LibiGel: Big Upside Potential: I have read your comments on Libi-Gel and they are well research... more »

Latest Comments on Mike Havrilla's Articles

Mike Havrilla » Articles » ALTH |

More on ALTH by Mike Havrilla

Articles by Ticker

Latest Comments on Mike Havrilla's Articles

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers